Filing Details
- Accession Number:
- 0001209191-14-007622
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-05 17:14:04
- Reporting Period:
- 2014-02-05
- Filing Date:
- 2014-02-05
- Accepted Time:
- 2014-02-05 17:14:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1346830 | Cara Therapeutics Inc. | CARA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
943431 | Joshua Ruch | C/O Rho Ventures 152 West 57Th Street, 23Rd Floor New York NY 10019 | No | No | Yes | No | |
1082907 | Habib Kairouz | C/O Rho Ventures 152 West 57Th Street, 23Rd Floor New York NY 10019 | No | No | Yes | No | |
1120545 | Mark Leschly | C/O Rho Ventures 152 West 57Th Street, 23Rd Floor New York NY 10019 | No | No | Yes | No | |
1325385 | Rho Capital Partners Llc | C/O Rho Ventures 152 West 57Th Street, 23Rd Floor New York NY 10019 | No | No | Yes | No | |
1419636 | Rho Ventures Vi Lp | 152 West 57Th Street, 23Rd Floor New York NY 10019 | No | No | Yes | No | |
1478944 | Rmv Vi, L.l.c. | C/O Rho Ventures 152 West 57Th Street, 23Rd Floor New York NY 10019 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-02-05 | 2,442,239 | $0.00 | 2,442,239 | No | 4 | C | Indirect | See Footnote |
Common Stock | Acquisiton | 2014-02-05 | 225,818 | $11.00 | 2,668,057 | No | 4 | P | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | See Footnote |
No | 4 | P | Indirect | See Footnote |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series D Preferred Stock | Disposition | 2014-02-05 | 6,105,598 | $0.00 | 2,442,239 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect |
Footnotes
- The Series D Preferred Stock held by Rho Ventures VI, L.P. ("Ventures") automatically converted on a 1-for-2.5 basis into shares of common stock upon the closing of the issuer's initial public offering.
- These securities are owned directly by Ventures. RMV VI, L.L.C. ("RMV") is the general partner of Ventures and Rho Capital Partners LLC ("Partners") is the managing member of RMV. Mark Leschly, Habib Kairouz and Joshua Ruch are managing members of Partners and exercise shared voting and investment power with respect to the shares owned by Ventures. Each of the reporting persons disclaims beneficial ownership of such securities, except to the extent of his or its respective pecuniary interest therein.